These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33677052)

  • 21. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
    Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
    Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
    Paulino AC; Mahajan A; Ye R; Grosshans DR; Fatih Okcu M; Su J; McAleer MF; McGovern S; Mangona VA; Chintagumpala M
    Radiother Oncol; 2018 Jul; 128(1):128-132. PubMed ID: 29373195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Das N; Kaushal D; Patro SK; Pareek P; Dixit A; Soni K; Prakasan Nair N; Choudhury B; Goyal A
    Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ototoxicity of preradiation cisplatin for children with central nervous system tumors.
    Kretschmar CS; Warren MP; Lavally BL; Dyer S; Tarbell NJ
    J Clin Oncol; 1990 Jul; 8(7):1191-8. PubMed ID: 2358836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose.
    Hua C; Bass JK; Khan R; Kun LE; Merchant TE
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):892-9. PubMed ID: 18395355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
    Langer T; Clemens E; Broer L; Maier L; Uitterlinden AG; de Vries ACH; van Grotel M; Pluijm SFM; Binder H; Mayer B; von dem Knesebeck A; Byrne J; van Dulmen-den Broeder E; Crocco M; Grabow D; Kaatsch P; Kaiser M; Spix C; Kenborg L; Winther JF; Rechnitzer C; Hasle H; Kepak T; van der Kooi AF; Kremer LC; Kruseova J; Bielack S; Sorg B; Hecker-Nolting S; Kuehni CE; Ansari M; Kompis M; van der Pal H; Parfitt R; Deuster D; Matulat P; Tillmanns A; Tissing WJE; Beck JD; Elsner S; Am Zehnhoff-Dinnesen A; van den Heuvel-Eibrink MM; Zolk O;
    Eur J Cancer; 2020 Oct; 138():212-224. PubMed ID: 32905960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in ototoxicity monitoring in the pediatric oncology population.
    Bass JK; Bhagat SP
    J Am Acad Audiol; 2014 Sep; 25(8):760-74; quiz 782-3. PubMed ID: 25380122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ
    Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
    Fetoni AR; Brigato F; De Corso E; Lucidi D; Sergi B; Scarano E; Galli J; Ruggiero A
    Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4677-4686. PubMed ID: 35024956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric analysis of hearing loss after cranial radiation therapy in children: A single-institution study from the French national registry PediaRT.
    Gehin W; Chastagner P; Mansuy L; Bernier-Chastagner V
    Radiother Oncol; 2024 Aug; 197():110346. PubMed ID: 38806115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hearing Loss After Radiation and Chemotherapy for CNS and Head-and-Neck Tumors in Children.
    Keilty D; Khandwala M; Liu ZA; Papaioannou V; Bouffet E; Hodgson D; Yee R; Cushing S; Laperriere N; Ahmed S; Mabbott D; Ramaswamy V; Tabori U; Huang A; Bartels U; Tsang DS
    J Clin Oncol; 2021 Dec; 39(34):3813-3821. PubMed ID: 34570616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.
    Yancey A; Harris MS; Egbelakin A; Gilbert J; Pisoni DB; Renbarger J
    Pediatr Blood Cancer; 2012 Jul; 59(1):144-8. PubMed ID: 22431292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Risk Factors Causing Ototoxicity in Childhood Cancers Located in the Head and Neck Region Treated With Platinum-based Chemotherapy.
    Olgun Y; Çakir Kizmazoğlu D; İnce D; Ellidokuz H; Güneri EA; Olgun N; Kirkim G
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e930-e934. PubMed ID: 33885038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
    Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
    Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
    Theunissen EA; Zuur CL; Józwiak K; Lopez-Yurda M; Hauptmann M; Rasch CR; van der Baan S; de Boer JP; Dreschler WA; Balm AJ
    JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):810-5. PubMed ID: 26291150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].
    Espenel S; Garcia MA; Guy JB; Vallard A; Ben Mrad M; Langrand-Escure J; El Meddeb Hamrouni A; Trone JC; Xia Y; Rancoule C; Magné N
    Cancer Radiother; 2017 Feb; 21(1):77-83. PubMed ID: 28189351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
    Fetoni AR; Ruggiero A; Lucidi D; De Corso E; Sergi B; Conti G; Paludetti G
    Audiol Neurootol; 2016; 21(4):203-211. PubMed ID: 27286730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.